date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.426657912380658.
The log-likelihood improved by 2.492.
Iteration 2 of at most 500:
Optimizing with step length 0.832926205228754.
The log-likelihood improved by 3.214.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2946.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2469.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       19     1256     1062      763      351      380      328 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     307      223      140       76       47       21       16        3 
degree16 degree19 
       3        1 
1 
disease_progression 
H-positive risk:  863 913 114 881 459 109 881 428 128 38 121 65 
H-negative risk:  913 863 881 881 428 459 109 114 121 128 65 38 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
62 new agents 
2 
disease_progression 
H-positive risk:  866 916 112 884 453 109 878 433 127 38 119 65 
H-negative risk:  916 866 878 884 433 453 109 112 119 127 65 38 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
3 
disease_progression 
H-positive risk:  869 921 114 884 449 108 878 429 128 38 118 64 
H-negative risk:  921 869 878 884 429 449 108 114 118 128 64 38 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 3 1 

clinical_engagement 
diagnosis 
demography 
58 new agents 
4 
disease_progression 
H-positive risk:  879 919 116 878 445 112 878 428 126 37 117 65 
H-negative risk:  919 879 878 878 428 445 112 116 117 126 65 37 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
67 new agents 
5 
disease_progression 
H-positive risk:  881 920 115 885 435 114 878 429 127 34 119 63 
H-negative risk:  920 881 878 885 429 435 114 115 119 127 63 34 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
6 
disease_progression 
H-positive risk:  882 923 115 882 439 117 880 421 125 35 117 64 
H-negative risk:  923 882 880 882 421 439 117 115 117 125 64 35 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 7 1 

clinical_engagement 
diagnosis 
demography 
67 new agents 
7 
disease_progression 
H-positive risk:  883 923 114 877 442 118 884 420 122 35 119 63 
H-negative risk:  923 883 884 877 420 442 118 114 119 122 63 35 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
76 new agents 
8 
disease_progression 
H-positive risk:  891 931 117 874 439 118 887 411 120 36 116 60 
H-negative risk:  931 891 887 874 411 439 118 117 116 120 60 36 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 12 2 

clinical_engagement 
diagnosis 
demography 
65 new agents 
9 
disease_progression 
H-positive risk:  891 938 120 872 431 116 889 410 121 35 117 60 
H-negative risk:  938 891 889 872 410 431 116 120 117 121 60 35 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
64 new agents 
10 
disease_progression 
H-positive risk:  900 936 120 870 424 117 887 411 124 36 116 59 
H-negative risk:  936 900 887 870 411 424 117 120 116 124 59 36 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 14 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
11 
disease_progression 
H-positive risk:  906 938 122 866 427 117 886 404 124 36 116 58 
H-negative risk:  938 906 886 866 404 427 117 122 116 124 58 36 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
12 
disease_progression 
H-positive risk:  909 944 123 869 417 118 884 400 127 36 116 57 
H-negative risk:  944 909 884 869 400 417 118 123 116 127 57 36 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 20 2 

clinical_engagement 
diagnosis 
demography 
71 new agents 
13 
disease_progression 
H-positive risk:  833 864 111 954 416 112 962 398 131 35 127 57 
H-negative risk:  864 833 962 954 398 416 112 111 127 131 57 35 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 20 2 

clinical_engagement 
diagnosis 
demography 
218 new agents 
14 
disease_progression 
H-positive risk:  865 897 115 918 408 117 918 420 120 44 120 58 
H-negative risk:  897 865 918 918 420 408 117 115 120 120 58 44 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 23 3 

clinical_engagement 
diagnosis 
demography 
68 new agents 
15 
disease_progression 
H-positive risk:  861 902 115 923 402 126 916 414 121 43 120 57 
H-negative risk:  902 861 916 923 414 402 126 115 120 121 57 43 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 24 3 

clinical_engagement 
diagnosis 
demography 
62 new agents 
16 
disease_progression 
H-positive risk:  865 902 116 921 399 127 916 410 121 44 122 57 
H-negative risk:  902 865 916 921 410 399 127 116 122 121 57 44 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 25 3 

clinical_engagement 
diagnosis 
demography 
56 new agents 
17 
disease_progression 
H-positive risk:  878 906 117 919 398 127 908 407 121 43 120 56 
H-negative risk:  906 878 908 919 407 398 127 117 120 121 56 43 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 25 4 

clinical_engagement 
diagnosis 
demography 
67 new agents 
18 
disease_progression 
H-positive risk:  879 911 118 919 394 127 904 403 124 42 122 57 
H-negative risk:  911 879 904 919 403 394 127 118 122 124 57 42 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 27 4 

clinical_engagement 
diagnosis 
demography 
74 new agents 
19 
disease_progression 
H-positive risk:  886 909 118 917 389 132 902 399 126 40 125 57 
H-negative risk:  909 886 902 917 399 389 132 118 125 126 57 40 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 32 4 

clinical_engagement 
diagnosis 
demography 
59 new agents 
20 
disease_progression 
H-positive risk:  890 919 120 915 385 131 893 400 125 39 125 58 
H-negative risk:  919 890 893 915 400 385 131 120 125 125 58 39 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 32 4 

clinical_engagement 
diagnosis 
demography 
88 new agents 
21 
disease_progression 
H-positive risk:  896 926 122 912 383 134 890 393 124 38 123 59 
H-negative risk:  926 896 890 912 393 383 134 122 123 124 59 38 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 35 4 

clinical_engagement 
diagnosis 
demography 
51 new agents 
22 
disease_progression 
H-positive risk:  902 931 122 914 381 134 889 388 125 38 120 56 
H-negative risk:  931 902 889 914 388 381 134 122 120 125 56 38 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 37 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
23 
disease_progression 
H-positive risk:  909 935 124 907 373 136 888 388 128 38 120 54 
H-negative risk:  935 909 888 907 388 373 136 124 120 128 54 38 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 42 5 

clinical_engagement 
diagnosis 
demography 
56 new agents 
24 
disease_progression 
H-positive risk:  909 943 126 908 362 136 892 384 130 38 120 52 
H-negative risk:  943 909 892 908 384 362 136 126 120 130 52 38 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 43 5 

clinical_engagement 
diagnosis 
demography 
57 new agents 
25 
disease_progression 
H-positive risk:  831 872 118 981 358 128 967 384 142 38 128 53 
H-negative risk:  872 831 967 981 384 358 128 118 128 142 53 38 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 42 5 

clinical_engagement 
diagnosis 
demography 
177 new agents 
26 
disease_progression 
H-positive risk:  851 906 121 946 372 133 916 406 138 38 121 52 
H-negative risk:  906 851 916 946 406 372 133 121 121 138 52 38 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 43 5 

clinical_engagement 
diagnosis 
demography 
75 new agents 
27 
disease_progression 
H-positive risk:  858 908 120 944 368 134 905 413 141 38 120 51 
H-negative risk:  908 858 905 944 413 368 134 120 120 141 51 38 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 47 5 

clinical_engagement 
diagnosis 
demography 
73 new agents 
28 
disease_progression 
H-positive risk:  862 910 124 936 364 137 904 416 140 37 120 50 
H-negative risk:  910 862 904 936 416 364 137 124 120 140 50 37 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 48 6 

clinical_engagement 
diagnosis 
demography 
43 new agents 
29 
disease_progression 
H-positive risk:  865 911 123 929 369 137 906 409 142 37 121 51 
H-negative risk:  911 865 906 929 409 369 137 123 121 142 51 37 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 50 6 

clinical_engagement 
diagnosis 
demography 
55 new agents 
30 
disease_progression 
H-positive risk:  868 909 124 930 368 138 908 407 142 37 121 48 
H-negative risk:  909 868 908 930 407 368 138 124 121 142 48 37 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 49 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
31 
disease_progression 
H-positive risk:  873 909 125 924 373 140 904 406 143 35 120 48 
H-negative risk:  909 873 904 924 406 373 140 125 120 143 48 35 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 50 7 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  874 908 126 920 383 141 901 401 143 37 117 49 
H-negative risk:  908 874 901 920 401 383 141 126 117 143 49 37 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 49 7 

clinical_engagement 
diagnosis 
demography 
66 new agents 
33 
disease_progression 
H-positive risk:  882 911 128 918 383 137 893 400 144 37 118 49 
H-negative risk:  911 882 893 918 400 383 137 128 118 144 49 37 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 52 7 

clinical_engagement 
diagnosis 
demography 
56 new agents 
34 
disease_progression 
H-positive risk:  886 911 128 918 383 137 892 397 143 37 118 50 
H-negative risk:  911 886 892 918 397 383 137 128 118 143 50 37 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 52 8 

clinical_engagement 
diagnosis 
demography 
67 new agents 
35 
disease_progression 
H-positive risk:  887 911 130 925 380 135 886 398 144 37 117 50 
H-negative risk:  911 887 886 925 398 380 135 130 117 144 50 37 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 56 8 

clinical_engagement 
diagnosis 
demography 
61 new agents 
36 
disease_progression 
H-positive risk:  889 910 129 921 384 133 883 396 146 40 118 51 
H-negative risk:  910 889 883 921 396 384 133 129 118 146 51 40 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 59 9 

clinical_engagement 
diagnosis 
demography 
53 new agents 
37 
disease_progression 
H-positive risk:  828 837 121 995 377 120 941 397 162 40 132 50 
H-negative risk:  837 828 941 995 397 377 120 121 132 162 50 40 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 60 9 

clinical_engagement 
diagnosis 
demography 
168 new agents 
38 
disease_progression 
H-positive risk:  851 849 124 950 383 125 921 411 165 37 129 55 
H-negative risk:  849 851 921 950 411 383 125 124 129 165 55 37 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 57 11 

clinical_engagement 
diagnosis 
demography 
62 new agents 
39 
disease_progression 
H-positive risk:  853 849 124 942 386 123 925 408 167 37 130 56 
H-negative risk:  849 853 925 942 408 386 123 124 130 167 56 37 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 59 11 

clinical_engagement 
diagnosis 
demography 
84 new agents 
40 
disease_progression 
H-positive risk:  860 850 123 943 379 122 935 399 167 38 131 53 
H-negative risk:  850 860 935 943 399 379 122 123 131 167 53 38 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 63 12 

clinical_engagement 
diagnosis 
demography 
71 new agents 
41 
disease_progression 
H-positive risk:  858 851 125 950 367 122 941 393 167 39 132 55 
H-negative risk:  851 858 941 950 393 367 122 125 132 167 55 39 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 65 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
42 
disease_progression 
H-positive risk:  865 854 124 952 360 123 944 387 165 39 134 53 
H-negative risk:  854 865 944 952 387 360 123 124 134 165 53 39 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 66 13 

clinical_engagement 
diagnosis 
demography 
55 new agents 
43 
disease_progression 
H-positive risk:  875 856 123 949 358 123 938 387 166 41 132 52 
H-negative risk:  856 875 938 949 387 358 123 123 132 166 52 41 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 66 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
44 
disease_progression 
H-positive risk:  879 847 120 949 360 127 939 387 166 42 133 51 
H-negative risk:  847 879 939 949 387 360 127 120 133 166 51 42 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 65 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
45 
disease_progression 
H-positive risk:  885 845 118 958 356 129 933 384 168 39 135 50 
H-negative risk:  845 885 933 958 384 356 129 118 135 168 50 39 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
46 
disease_progression 
H-positive risk:  893 851 116 965 352 129 929 375 168 37 135 50 
H-negative risk:  851 893 929 965 375 352 129 116 135 168 50 37 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
47 
disease_progression 
H-positive risk:  895 852 114 962 354 130 926 373 167 40 138 49 
H-negative risk:  852 895 926 962 373 354 130 114 138 167 49 40 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
48 
disease_progression 
H-positive risk:  906 855 115 960 357 128 920 371 164 38 138 48 
H-negative risk:  855 906 920 960 371 357 128 115 138 164 48 38 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
49 
disease_progression 
H-positive risk:  842 793 109 1026 349 120 991 367 169 41 145 48 
H-negative risk:  793 842 991 1026 367 349 120 109 145 169 48 41 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
111 new agents 
50 
disease_progression 
H-positive risk:  848 793 107 1002 363 123 968 392 160 47 147 50 
H-negative risk:  793 848 968 1002 392 363 123 107 147 160 50 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
51 
disease_progression 
H-positive risk:  851 791 110 1008 360 122 969 386 157 46 147 53 
H-negative risk:  791 851 969 1008 386 360 122 110 147 157 53 46 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
52 
disease_progression 
H-positive risk:  845 792 108 1012 355 121 982 385 154 46 147 53 
H-negative risk:  792 845 982 1012 385 355 121 108 147 154 53 46 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
53 
disease_progression 
H-positive risk:  843 798 106 1007 364 124 974 390 153 43 148 50 
H-negative risk:  798 843 974 1007 390 364 124 106 148 153 50 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
54 
disease_progression 
H-positive risk:  843 801 108 1009 361 122 974 388 153 42 148 51 
H-negative risk:  801 843 974 1009 388 361 122 108 148 153 51 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
55 
disease_progression 
H-positive risk:  844 809 110 1006 362 122 966 385 153 43 148 52 
H-negative risk:  809 844 966 1006 385 362 122 110 148 153 52 43 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
56 
disease_progression 
H-positive risk:  848 813 108 1007 363 123 964 381 151 43 150 49 
H-negative risk:  813 848 964 1007 381 363 123 108 150 151 49 43 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
57 
disease_progression 
H-positive risk:  847 817 106 1000 368 127 961 380 150 44 150 50 
H-negative risk:  817 847 961 1000 380 368 127 106 150 150 50 44 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
58 
disease_progression 
H-positive risk:  852 823 106 996 358 127 961 376 150 47 152 52 
H-negative risk:  823 852 961 996 376 358 127 106 152 150 52 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
59 
disease_progression 
H-positive risk:  855 832 105 995 358 130 962 372 147 45 150 49 
H-negative risk:  832 855 962 995 372 358 130 105 150 147 49 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
60 
disease_progression 
H-positive risk:  860 828 103 1001 359 132 960 369 145 45 149 49 
H-negative risk:  828 860 960 1001 369 359 132 103 149 145 49 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
61 
disease_progression 
H-positive risk:  823 786 99 1053 357 122 994 366 151 46 155 48 
H-negative risk:  786 823 994 1053 366 357 122 99 155 151 48 46 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
131 new agents 
62 
disease_progression 
H-positive risk:  825 806 99 1030 364 121 979 372 146 54 150 54 
H-negative risk:  806 825 979 1030 372 364 121 99 150 146 54 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
63 
disease_progression 
H-positive risk:  821 814 99 1025 364 120 979 375 145 55 148 55 
H-negative risk:  814 821 979 1025 375 364 120 99 148 145 55 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
64 
disease_progression 
H-positive risk:  812 817 98 1027 368 123 971 379 145 56 150 54 
H-negative risk:  817 812 971 1027 379 368 123 98 150 145 54 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
65 
disease_progression 
H-positive risk:  822 813 99 1025 363 126 971 373 145 55 153 55 
H-negative risk:  813 822 971 1025 373 363 126 99 153 145 55 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
66 
disease_progression 
H-positive risk:  825 812 99 1027 357 127 976 369 146 54 153 55 
H-negative risk:  812 825 976 1027 369 357 127 99 153 146 55 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
67 
disease_progression 
H-positive risk:  831 813 101 1017 360 127 981 366 142 54 154 54 
H-negative risk:  813 831 981 1017 366 360 127 101 154 142 54 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
68 
disease_progression 
H-positive risk:  828 813 101 1011 366 126 984 368 145 52 150 56 
H-negative risk:  813 828 984 1011 368 366 126 101 150 145 56 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
69 
disease_progression 
H-positive risk:  833 817 101 1008 366 121 981 372 145 50 150 56 
H-negative risk:  817 833 981 1008 372 366 121 101 150 145 56 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
70 
disease_progression 
H-positive risk:  830 825 104 1006 359 124 983 370 144 49 149 57 
H-negative risk:  825 830 983 1006 370 359 124 104 149 144 57 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
52 new agents 
71 
disease_progression 
H-positive risk:  837 823 105 1005 358 127 978 369 143 50 149 56 
H-negative risk:  823 837 978 1005 369 358 127 105 149 143 56 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
72 
disease_progression 
H-positive risk:  839 823 103 1000 360 127 975 377 141 51 148 56 
H-negative risk:  823 839 975 1000 377 360 127 103 148 141 56 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
73 
disease_progression 
H-positive risk:  791 772 95 1059 355 123 1019 381 146 51 154 54 
H-negative risk:  772 791 1019 1059 381 355 123 95 154 146 54 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
101 new agents 
74 
disease_progression 
H-positive risk:  787 762 95 1036 378 123 1005 406 146 55 149 58 
H-negative risk:  762 787 1005 1036 406 378 123 95 149 146 58 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
75 
disease_progression 
H-positive risk:  795 759 95 1034 381 125 992 407 146 58 150 58 
H-negative risk:  759 795 992 1034 407 381 125 95 150 146 58 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
76 
disease_progression 
H-positive risk:  795 767 97 1039 382 123 988 404 146 57 148 54 
H-negative risk:  767 795 988 1039 404 382 123 97 148 146 54 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
77 
disease_progression 
H-positive risk:  790 769 97 1038 374 125 1002 401 147 58 146 53 
H-negative risk:  769 790 1002 1038 401 374 125 97 146 147 53 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
78 
disease_progression 
H-positive risk:  794 766 97 1043 372 125 996 403 146 58 147 53 
H-negative risk:  766 794 996 1043 403 372 125 97 147 146 53 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
79 
disease_progression 
H-positive risk:  797 769 98 1047 376 124 999 393 141 56 148 52 
H-negative risk:  769 797 999 1047 393 376 124 98 148 141 52 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
80 
disease_progression 
H-positive risk:  799 761 98 1052 385 126 1002 383 142 55 148 49 
H-negative risk:  761 799 1002 1052 383 385 126 98 148 142 49 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
81 
disease_progression 
H-positive risk:  796 763 98 1048 391 130 1007 377 140 56 145 49 
H-negative risk:  763 796 1007 1048 377 391 130 98 145 140 49 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
82 
disease_progression 
H-positive risk:  796 764 101 1048 386 130 1011 372 141 57 144 50 
H-negative risk:  764 796 1011 1048 372 386 130 101 144 141 50 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
83 
disease_progression 
H-positive risk:  785 775 100 1055 376 129 1016 375 138 58 144 49 
H-negative risk:  775 785 1016 1055 375 376 129 100 144 138 49 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
84 
disease_progression 
H-positive risk:  787 772 101 1053 372 129 1018 379 139 58 143 49 
H-negative risk:  772 787 1018 1053 379 372 129 101 143 139 49 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
85 
disease_progression 
H-positive risk:  750 730 99 1105 368 124 1063 368 143 55 148 47 
H-negative risk:  730 750 1063 1105 368 368 124 99 148 143 47 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
106 new agents 
86 
disease_progression 
H-positive risk:  747 728 98 1087 380 125 1044 389 139 59 150 54 
H-negative risk:  728 747 1044 1087 389 380 125 98 150 139 54 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
87 
disease_progression 
H-positive risk:  748 730 99 1079 386 128 1039 391 138 58 147 57 
H-negative risk:  730 748 1039 1079 391 386 128 99 147 138 57 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
88 
disease_progression 
H-positive risk:  752 734 95 1080 383 129 1040 382 140 58 147 60 
H-negative risk:  734 752 1040 1080 382 383 129 95 147 140 60 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
89 
disease_progression 
H-positive risk:  750 737 94 1083 380 128 1041 379 139 58 148 63 
H-negative risk:  737 750 1041 1083 379 380 128 94 148 139 63 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
90 
disease_progression 
H-positive risk:  756 738 93 1090 372 129 1034 379 139 58 147 65 
H-negative risk:  738 756 1034 1090 379 372 129 93 147 139 65 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
91 
disease_progression 
H-positive risk:  755 743 93 1076 373 130 1043 382 136 58 146 65 
H-negative risk:  743 755 1043 1076 382 373 130 93 146 136 65 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
92 
disease_progression 
H-positive risk:  751 739 95 1088 365 131 1051 377 138 60 143 62 
H-negative risk:  739 751 1051 1088 377 365 131 95 143 138 62 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
93 
disease_progression 
H-positive risk:  748 742 96 1097 359 127 1051 374 140 60 143 63 
H-negative risk:  742 748 1051 1097 374 359 127 96 143 140 63 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
94 
disease_progression 
H-positive risk:  753 732 94 1100 352 126 1060 374 140 60 144 65 
H-negative risk:  732 753 1060 1100 374 352 126 94 144 140 65 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
95 
disease_progression 
H-positive risk:  752 736 96 1090 355 125 1057 378 139 61 146 65 
H-negative risk:  736 752 1057 1090 378 355 125 96 146 139 65 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
96 
disease_progression 
H-positive risk:  753 734 99 1095 351 123 1051 382 139 62 147 64 
H-negative risk:  734 753 1051 1095 382 351 123 99 147 139 64 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
97 
disease_progression 
H-positive risk:  709 682 95 1149 350 119 1087 385 143 62 153 66 
H-negative risk:  682 709 1087 1149 385 350 119 95 153 143 66 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
99 new agents 
98 
disease_progression 
H-positive risk:  711 693 97 1137 355 119 1065 402 144 61 145 71 
H-negative risk:  693 711 1065 1137 402 355 119 97 145 144 71 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
99 
disease_progression 
H-positive risk:  717 695 97 1133 358 118 1052 411 148 61 142 68 
H-negative risk:  695 717 1052 1133 411 358 118 97 142 148 68 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
100 
disease_progression 
H-positive risk:  721 694 101 1136 360 117 1047 414 144 59 141 66 
H-negative risk:  694 721 1047 1136 414 360 117 101 141 144 66 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
101 
disease_progression 
H-positive risk:  725 697 102 1124 364 116 1048 410 148 57 144 65 
H-negative risk:  697 725 1048 1124 410 364 116 102 144 148 65 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
102 
disease_progression 
H-positive risk:  727 703 104 1125 368 117 1037 411 147 57 143 61 
H-negative risk:  703 727 1037 1125 411 368 117 104 143 147 61 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
103 
disease_progression 
H-positive risk:  724 704 105 1131 370 115 1038 407 148 55 142 61 
H-negative risk:  704 724 1038 1131 407 370 115 105 142 148 61 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
104 
disease_progression 
H-positive risk:  729 701 105 1137 370 114 1034 404 150 53 142 61 
H-negative risk:  701 729 1034 1137 404 370 114 105 142 150 61 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
105 
disease_progression 
H-positive risk:  734 698 103 1134 378 112 1033 405 150 52 141 60 
H-negative risk:  698 734 1033 1134 405 378 112 103 141 150 60 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
106 
disease_progression 
H-positive risk:  745 699 104 1125 381 114 1034 398 147 51 139 63 
H-negative risk:  699 745 1034 1125 398 381 114 104 139 147 63 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
107 
disease_progression 
H-positive risk:  748 694 103 1129 370 116 1036 402 144 54 141 63 
H-negative risk:  694 748 1036 1129 402 370 116 103 141 144 63 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
50 new agents 
108 
disease_progression 
H-positive risk:  742 696 103 1129 375 115 1035 404 143 55 138 65 
H-negative risk:  696 742 1035 1129 404 375 115 103 138 143 65 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
109 
disease_progression 
H-positive risk:  715 652 98 1170 375 110 1055 412 147 57 143 66 
H-negative risk:  652 715 1055 1170 412 375 110 98 143 147 66 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
108 new agents 
110 
disease_progression 
H-positive risk:  715 640 98 1166 381 111 1055 422 150 55 143 64 
H-negative risk:  640 715 1055 1166 422 381 111 98 143 150 64 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
90 new agents 
111 
disease_progression 
H-positive risk:  716 649 98 1160 384 106 1060 416 153 53 142 63 
H-negative risk:  649 716 1060 1160 416 384 106 98 142 153 63 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
112 
disease_progression 
H-positive risk:  717 651 100 1157 376 107 1064 418 154 55 140 61 
H-negative risk:  651 717 1064 1157 418 376 107 100 140 154 61 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
113 
disease_progression 
H-positive risk:  724 655 100 1146 372 109 1069 415 155 53 144 58 
H-negative risk:  655 724 1069 1146 415 372 109 100 144 155 58 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
114 
disease_progression 
H-positive risk:  720 652 101 1137 377 110 1069 422 157 53 143 59 
H-negative risk:  652 720 1069 1137 422 377 110 101 143 157 59 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
115 
disease_progression 
H-positive risk:  711 660 99 1137 382 110 1066 418 161 51 146 59 
H-negative risk:  660 711 1066 1137 418 382 110 99 146 161 59 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
116 
disease_progression 
H-positive risk:  715 660 96 1147 384 109 1053 418 163 49 147 59 
H-negative risk:  660 715 1053 1147 418 384 109 96 147 163 59 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
117 
disease_progression 
H-positive risk:  706 659 96 1141 388 111 1062 413 162 51 151 60 
H-negative risk:  659 706 1062 1141 413 388 111 96 151 162 60 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
118 
disease_progression 
H-positive risk:  701 664 95 1125 393 112 1068 416 164 54 150 58 
H-negative risk:  664 701 1068 1125 416 393 112 95 150 164 58 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
119 
disease_progression 
H-positive risk:  695 669 97 1127 386 112 1075 411 162 55 151 60 
H-negative risk:  669 695 1075 1127 411 386 112 97 151 162 60 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
120 
disease_progression 
H-positive risk:  690 669 96 1131 393 113 1077 404 161 53 151 62 
H-negative risk:  669 690 1077 1131 404 393 113 96 151 161 62 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
121 
disease_progression 
H-positive risk:  641 640 91 1165 390 107 1132 402 166 47 157 62 
H-negative risk:  640 641 1132 1165 402 390 107 91 157 166 62 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
122 
disease_progression 
H-positive risk:  635 640 92 1155 405 103 1128 404 164 50 160 64 
H-negative risk:  640 635 1128 1155 404 405 103 92 160 164 64 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
123 
disease_progression 
H-positive risk:  630 634 90 1160 411 102 1128 403 160 54 163 65 
H-negative risk:  634 630 1128 1160 403 411 102 90 163 160 65 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
124 
disease_progression 
H-positive risk:  630 634 90 1157 416 100 1126 401 160 54 164 68 
H-negative risk:  634 630 1126 1157 401 416 100 90 164 160 68 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
125 
disease_progression 
H-positive risk:  635 631 88 1153 421 94 1135 393 163 55 168 64 
H-negative risk:  631 635 1135 1153 393 421 94 88 168 163 64 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
126 
disease_progression 
H-positive risk:  639 631 85 1151 417 93 1141 393 164 53 169 64 
H-negative risk:  631 639 1141 1151 393 417 93 85 169 164 64 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
127 
disease_progression 
H-positive risk:  643 630 88 1146 415 91 1141 394 163 52 169 68 
H-negative risk:  630 643 1141 1146 394 415 91 88 169 163 68 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
128 
disease_progression 
H-positive risk:  640 632 89 1147 412 92 1147 391 163 52 169 66 
H-negative risk:  632 640 1147 1147 391 412 92 89 169 163 66 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
129 
disease_progression 
H-positive risk:  636 630 91 1150 410 92 1142 395 164 55 170 65 
H-negative risk:  630 636 1142 1150 395 410 92 91 170 164 65 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
130 
disease_progression 
H-positive risk:  631 629 89 1162 410 93 1129 400 166 55 172 64 
H-negative risk:  629 631 1129 1162 400 410 93 89 172 166 64 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
131 
disease_progression 
H-positive risk:  632 638 89 1156 412 91 1126 396 166 56 176 62 
H-negative risk:  638 632 1126 1156 396 412 91 89 176 166 62 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
132 
disease_progression 
H-positive risk:  635 644 88 1152 410 88 1132 390 166 57 176 62 
H-negative risk:  644 635 1132 1152 390 410 88 88 176 166 62 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
133 
disease_progression 
H-positive risk:  634 637 90 1149 410 90 1137 389 165 58 178 63 
H-negative risk:  637 634 1137 1149 389 410 90 90 178 165 63 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
95 new agents 
134 
disease_progression 
H-positive risk:  631 629 89 1156 412 90 1138 386 169 57 179 64 
H-negative risk:  629 631 1138 1156 386 412 90 89 179 169 64 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
135 
disease_progression 
H-positive risk:  634 629 87 1155 413 91 1136 388 171 56 179 61 
H-negative risk:  629 634 1136 1155 388 413 91 87 179 171 61 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
136 
disease_progression 
H-positive risk:  636 635 90 1154 411 92 1133 386 171 56 173 63 
H-negative risk:  635 636 1133 1154 386 411 92 90 173 171 63 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
137 
disease_progression 
H-positive risk:  641 642 92 1145 405 92 1134 389 172 57 169 62 
H-negative risk:  642 641 1134 1145 389 405 92 92 169 172 62 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
138 
disease_progression 
H-positive risk:  643 641 93 1144 399 90 1145 391 169 57 166 62 
H-negative risk:  641 643 1145 1144 391 399 90 93 166 169 62 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
139 
disease_progression 
H-positive risk:  648 645 91 1138 394 93 1149 390 169 57 165 61 
H-negative risk:  645 648 1149 1138 390 394 93 91 165 169 61 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
140 
disease_progression 
H-positive risk:  647 645 90 1145 400 89 1136 391 173 55 169 60 
H-negative risk:  645 647 1136 1145 391 400 89 90 169 173 60 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
141 
disease_progression 
H-positive risk:  642 656 90 1140 392 91 1145 387 174 57 166 60 
H-negative risk:  656 642 1145 1140 387 392 91 90 166 174 60 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
142 
disease_progression 
H-positive risk:  648 653 92 1133 395 90 1148 384 177 57 165 58 
H-negative risk:  653 648 1148 1133 384 395 90 92 165 177 58 57 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
143 
disease_progression 
H-positive risk:  651 654 89 1129 393 88 1156 384 176 56 165 59 
H-negative risk:  654 651 1156 1129 384 393 88 89 165 176 59 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
144 
disease_progression 
H-positive risk:  648 661 93 1125 397 88 1153 382 177 53 165 58 
H-negative risk:  661 648 1153 1125 382 397 88 93 165 177 58 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
145 
disease_progression 
H-positive risk:  658 664 92 1121 390 91 1152 381 179 52 163 57 
H-negative risk:  664 658 1152 1121 381 390 91 92 163 179 57 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
96 new agents 
146 
disease_progression 
H-positive risk:  661 670 90 1121 388 92 1145 382 180 54 157 60 
H-negative risk:  670 661 1145 1121 382 388 92 90 157 180 60 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
105 new agents 
147 
disease_progression 
H-positive risk:  662 668 89 1131 384 91 1152 374 177 56 156 60 
H-negative risk:  668 662 1152 1131 374 384 91 89 156 177 60 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
148 
disease_progression 
H-positive risk:  655 669 89 1119 386 90 1168 379 174 55 159 57 
H-negative risk:  669 655 1168 1119 379 386 90 89 159 174 57 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  651 669 91 1114 383 91 1172 377 177 57 160 58 
H-negative risk:  669 651 1172 1114 377 383 91 91 160 177 58 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
150 
disease_progression 
H-positive risk:  653 663 90 1119 382 94 1176 374 174 57 161 57 
H-negative risk:  663 653 1176 1119 374 382 94 90 161 174 57 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
151 
disease_progression 
H-positive risk:  660 678 91 1106 385 94 1168 368 174 59 161 56 
H-negative risk:  678 660 1168 1106 368 385 94 91 161 174 56 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
152 
disease_progression 
H-positive risk:  657 681 92 1106 386 95 1167 367 173 61 158 57 
H-negative risk:  681 657 1167 1106 367 386 95 92 158 173 57 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
153 
disease_progression 
H-positive risk:  659 679 91 1114 382 95 1161 375 172 59 156 57 
H-negative risk:  679 659 1161 1114 375 382 95 91 156 172 57 59 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
154 
disease_progression 
H-positive risk:  655 680 95 1115 379 92 1163 376 174 61 157 53 
H-negative risk:  680 655 1163 1115 376 379 92 95 157 174 53 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
155 
disease_progression 
H-positive risk:  659 681 97 1109 385 91 1165 365 173 63 160 52 
H-negative risk:  681 659 1165 1109 365 385 91 97 160 173 52 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
156 
disease_progression 
H-positive risk:  659 676 99 1119 381 91 1158 369 173 62 161 52 
H-negative risk:  676 659 1158 1119 369 381 91 99 161 173 52 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
157 
disease_progression 
H-positive risk:  657 679 96 1113 381 96 1156 374 172 63 163 50 
H-negative risk:  679 657 1156 1113 374 381 96 96 163 172 50 63 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
158 
disease_progression 
H-positive risk:  655 674 96 1114 398 96 1148 371 173 67 158 50 
H-negative risk:  674 655 1148 1114 371 398 96 96 158 173 50 67 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
159 
disease_progression 
H-positive risk:  658 680 97 1113 399 99 1136 369 170 71 155 53 
H-negative risk:  680 658 1136 1113 369 399 99 97 155 170 53 71 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
91 new agents 
160 
disease_progression 
H-positive risk:  654 685 99 1116 401 103 1141 362 167 73 147 52 
H-negative risk:  685 654 1141 1116 362 401 103 99 147 167 52 73 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 67 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
161 
disease_progression 
H-positive risk:  654 686 101 1108 409 107 1141 353 166 73 152 50 
H-negative risk:  686 654 1141 1108 353 409 107 101 152 166 50 73 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 67 17 

clinical_engagement 
diagnosis 
demography 
86 new agents 
162 
disease_progression 
H-positive risk:  652 689 101 1102 415 107 1154 347 163 70 150 50 
H-negative risk:  689 652 1154 1102 347 415 107 101 150 163 50 70 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 66 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
163 
disease_progression 
H-positive risk:  652 688 102 1103 415 106 1153 348 161 73 151 48 
H-negative risk:  688 652 1153 1103 348 415 106 102 151 161 48 73 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
164 
disease_progression 
H-positive risk:  649 691 103 1101 413 106 1162 344 161 75 149 46 
H-negative risk:  691 649 1162 1101 344 413 106 103 149 161 46 75 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
165 
disease_progression 
H-positive risk:  657 679 108 1106 404 106 1156 348 162 76 149 49 
H-negative risk:  679 657 1156 1106 348 404 106 108 149 162 49 76 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
166 
disease_progression 
H-positive risk:  659 682 109 1106 405 106 1152 346 167 74 145 49 
H-negative risk:  682 659 1152 1106 346 405 106 109 145 167 49 74 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
167 
disease_progression 
H-positive risk:  668 681 113 1101 408 106 1150 341 166 71 145 50 
H-negative risk:  681 668 1150 1101 341 408 106 113 145 166 50 71 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
168 
disease_progression 
H-positive risk:  670 681 113 1107 401 105 1147 344 170 68 140 54 
H-negative risk:  681 670 1147 1107 344 401 105 113 140 170 54 68 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
84 new agents 
169 
disease_progression 
H-positive risk:  671 683 115 1099 402 103 1160 344 169 64 139 51 
H-negative risk:  683 671 1160 1099 344 402 103 115 139 169 51 64 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  679 685 113 1090 413 104 1138 358 167 61 138 54 
H-negative risk:  685 679 1138 1090 358 413 104 113 138 167 54 61 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 63 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
171 
disease_progression 
H-positive risk:  678 685 113 1074 419 103 1146 361 166 62 139 54 
H-negative risk:  685 678 1146 1074 361 419 103 113 139 166 54 62 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 62 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
172 
disease_progression 
H-positive risk:  680 689 115 1080 418 102 1133 365 164 61 139 54 
H-negative risk:  689 680 1133 1080 365 418 102 115 139 164 54 61 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
173 
disease_progression 
H-positive risk:  673 688 111 1072 420 102 1141 367 167 60 143 56 
H-negative risk:  688 673 1141 1072 367 420 102 111 143 167 56 60 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
174 
disease_progression 
H-positive risk:  666 692 110 1073 424 104 1132 370 168 57 144 60 
H-negative risk:  692 666 1132 1073 370 424 104 110 144 168 60 57 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
175 
disease_progression 
H-positive risk:  658 684 107 1071 424 102 1137 378 171 58 147 63 
H-negative risk:  684 658 1137 1071 378 424 102 107 147 171 63 58 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 59 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
176 
disease_progression 
H-positive risk:  656 680 107 1069 421 101 1134 390 172 61 146 63 
H-negative risk:  680 656 1134 1069 390 421 101 107 146 172 63 61 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
177 
disease_progression 
H-positive risk:  659 682 107 1061 419 100 1130 392 174 63 151 62 
H-negative risk:  682 659 1130 1061 392 419 100 107 151 174 62 63 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 60 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
178 
disease_progression 
H-positive risk:  667 683 111 1059 414 99 1129 390 173 62 154 59 
H-negative risk:  683 667 1129 1059 390 414 99 111 154 173 59 62 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 61 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
179 
disease_progression 
H-positive risk:  665 677 113 1062 417 101 1128 386 173 61 158 59 
H-negative risk:  677 665 1128 1062 386 417 101 113 158 173 59 61 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
180 
disease_progression 
H-positive risk:  661 677 117 1063 418 102 1127 385 173 62 158 57 
H-negative risk:  677 661 1127 1063 385 418 102 117 158 173 57 62 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 64 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
181 
disease_progression 
H-positive risk:  660 675 116 1061 417 101 1147 377 168 67 155 56 
H-negative risk:  675 660 1147 1061 377 417 101 116 155 168 56 67 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
90 new agents 
182 
disease_progression 
H-positive risk:  672 665 116 1057 422 100 1136 382 168 65 154 63 
H-negative risk:  665 672 1136 1057 382 422 100 116 154 168 63 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
183 
disease_progression 
H-positive risk:  671 661 117 1060 426 100 1137 385 163 65 151 64 
H-negative risk:  661 671 1137 1060 385 426 100 117 151 163 64 65 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
184 
disease_progression 
H-positive risk:  669 657 121 1062 427 99 1138 386 165 63 147 66 
H-negative risk:  657 669 1138 1062 386 427 99 121 147 165 66 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
185 
disease_progression 
H-positive risk:  679 655 121 1055 436 101 1131 386 163 62 148 63 
H-negative risk:  655 679 1131 1055 386 436 101 121 148 163 63 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
186 
disease_progression 
H-positive risk:  685 664 126 1048 434 99 1126 380 164 65 143 66 
H-negative risk:  664 685 1126 1048 380 434 99 126 143 164 66 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
187 
disease_progression 
H-positive risk:  689 667 123 1048 431 104 1119 380 159 69 142 69 
H-negative risk:  667 689 1119 1048 380 431 104 123 142 159 69 69 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
188 
disease_progression 
H-positive risk:  688 663 122 1049 431 103 1127 379 160 70 140 68 
H-negative risk:  663 688 1127 1049 379 431 103 122 140 160 68 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
189 
disease_progression 
H-positive risk:  694 667 123 1053 423 103 1133 375 155 66 141 67 
H-negative risk:  667 694 1133 1053 375 423 103 123 141 155 67 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
190 
disease_progression 
H-positive risk:  698 664 124 1052 430 102 1122 376 153 66 145 68 
H-negative risk:  664 698 1122 1052 376 430 102 124 145 153 68 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
191 
disease_progression 
H-positive risk:  702 668 123 1044 432 104 1122 377 154 60 147 67 
H-negative risk:  668 702 1122 1044 377 432 104 123 147 154 67 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
192 
disease_progression 
H-positive risk:  702 680 125 1039 421 109 1112 381 156 60 146 69 
H-negative risk:  680 702 1112 1039 381 421 109 125 146 156 69 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
193 
disease_progression 
H-positive risk:  701 684 122 1048 410 110 1113 377 155 62 148 70 
H-negative risk:  684 701 1113 1048 377 410 110 122 148 155 70 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
194 
disease_progression 
H-positive risk:  706 677 121 1046 420 105 1102 390 156 64 148 65 
H-negative risk:  677 706 1102 1046 390 420 105 121 148 156 65 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
195 
disease_progression 
H-positive risk:  716 675 118 1036 424 108 1098 399 153 63 150 60 
H-negative risk:  675 716 1098 1036 399 424 108 118 150 153 60 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
196 
disease_progression 
H-positive risk:  716 676 114 1026 434 110 1099 396 149 66 152 62 
H-negative risk:  676 716 1099 1026 396 434 110 114 152 149 62 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
197 
disease_progression 
H-positive risk:  713 673 114 1028 433 109 1101 398 152 67 151 61 
H-negative risk:  673 713 1101 1028 398 433 109 114 151 152 61 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
96 new agents 
198 
disease_progression 
H-positive risk:  717 679 110 1041 431 109 1090 393 153 66 152 59 
H-negative risk:  679 717 1090 1041 393 431 109 110 152 153 59 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
199 
disease_progression 
H-positive risk:  715 681 113 1044 424 107 1090 396 155 64 155 56 
H-negative risk:  681 715 1090 1044 396 424 107 113 155 155 56 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
200 
disease_progression 
H-positive risk:  717 670 110 1052 427 103 1086 399 161 65 154 56 
H-negative risk:  670 717 1086 1052 399 427 103 110 154 161 56 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
201 
disease_progression 
H-positive risk:  716 663 109 1049 426 102 1095 405 159 67 155 54 
H-negative risk:  663 716 1095 1049 405 426 102 109 155 159 54 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
66 new agents 
202 
disease_progression 
H-positive risk:  718 674 106 1040 420 99 1099 404 162 68 155 55 
H-negative risk:  674 718 1099 1040 404 420 99 106 155 162 55 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
203 
disease_progression 
H-positive risk:  712 675 108 1046 410 101 1101 407 160 68 158 54 
H-negative risk:  675 712 1101 1046 407 410 101 108 158 160 54 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
204 
disease_progression 
H-positive risk:  707 669 109 1039 416 103 1108 412 161 68 155 53 
H-negative risk:  669 707 1108 1039 412 416 103 109 155 161 53 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
205 
disease_progression 
H-positive risk:  704 674 108 1032 420 101 1106 414 162 68 156 55 
H-negative risk:  674 704 1106 1032 414 420 101 108 156 162 55 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
206 
disease_progression 
H-positive risk:  700 676 104 1032 420 97 1103 426 156 71 163 52 
H-negative risk:  676 700 1103 1032 426 420 97 104 163 156 52 71 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
207 
disease_progression 
H-positive risk:  697 673 105 1036 423 97 1107 421 156 69 164 52 
H-negative risk:  673 697 1107 1036 421 423 97 105 164 156 52 69 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
208 
disease_progression 
H-positive risk:  708 677 103 1042 424 98 1083 425 154 72 163 51 
H-negative risk:  677 708 1083 1042 425 424 98 103 163 154 51 72 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
209 
disease_progression 
H-positive risk:  707 685 102 1045 413 98 1083 424 157 70 162 54 
H-negative risk:  685 707 1083 1045 424 413 98 102 162 157 54 70 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
210 
disease_progression 
H-positive risk:  705 682 102 1048 416 97 1074 432 159 66 163 56 
H-negative risk:  682 705 1074 1048 432 416 97 102 163 159 56 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
211 
disease_progression 
H-positive risk:  702 681 104 1045 414 96 1079 427 160 69 166 57 
H-negative risk:  681 702 1079 1045 427 414 96 104 166 160 57 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
212 
disease_progression 
H-positive risk:  703 683 104 1042 417 95 1077 430 161 65 166 57 
H-negative risk:  683 703 1077 1042 430 417 95 104 166 161 57 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
213 
disease_progression 
H-positive risk:  704 686 102 1041 415 97 1073 435 161 62 164 60 
H-negative risk:  686 704 1073 1041 435 415 97 102 164 161 60 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
214 
disease_progression 
H-positive risk:  700 687 99 1041 406 100 1081 438 162 62 163 61 
H-negative risk:  687 700 1081 1041 438 406 100 99 163 162 61 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
215 
disease_progression 
H-positive risk:  694 689 98 1041 407 103 1083 440 161 64 162 58 
H-negative risk:  689 694 1083 1041 440 407 103 98 162 161 58 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
216 
disease_progression 
H-positive risk:  696 688 95 1041 408 103 1083 437 163 64 166 56 
H-negative risk:  688 696 1083 1041 437 408 103 95 166 163 56 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
217 
disease_progression 
H-positive risk:  697 681 95 1028 423 100 1083 435 167 66 164 61 
H-negative risk:  681 697 1083 1028 435 423 100 95 164 167 61 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
218 
disease_progression 
H-positive risk:  699 684 95 1032 422 104 1079 434 158 68 163 62 
H-negative risk:  684 699 1079 1032 434 422 104 95 163 158 62 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
83 new agents 
219 
disease_progression 
H-positive risk:  698 690 94 1030 424 105 1077 433 156 72 156 65 
H-negative risk:  690 698 1077 1030 433 424 105 94 156 156 65 72 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
79 new agents 
220 
disease_progression 
H-positive risk:  698 685 92 1032 422 104 1076 440 155 75 154 67 
H-negative risk:  685 698 1076 1032 440 422 104 92 154 155 67 75 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
221 
disease_progression 
H-positive risk:  699 694 89 1023 421 103 1067 450 154 77 158 65 
H-negative risk:  694 699 1067 1023 450 421 103 89 158 154 65 77 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 80 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
222 
disease_progression 
H-positive risk:  697 689 88 1033 425 104 1069 451 150 73 156 65 
H-negative risk:  689 697 1069 1033 451 425 104 88 156 150 65 73 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
223 
disease_progression 
H-positive risk:  696 688 88 1038 423 103 1068 450 150 72 159 65 
H-negative risk:  688 696 1068 1038 450 423 103 88 159 150 65 72 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
224 
disease_progression 
H-positive risk:  695 686 89 1033 423 105 1074 450 148 72 160 65 
H-negative risk:  686 695 1074 1033 450 423 105 89 160 148 65 72 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
225 
disease_progression 
H-positive risk:  697 687 89 1032 415 107 1075 453 145 74 161 65 
H-negative risk:  687 697 1075 1032 453 415 107 89 161 145 65 74 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
226 
disease_progression 
H-positive risk:  700 687 87 1027 415 106 1080 455 147 73 161 62 
H-negative risk:  687 700 1080 1027 455 415 106 87 161 147 62 73 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
227 
disease_progression 
H-positive risk:  701 681 90 1027 414 108 1080 454 148 76 161 60 
H-negative risk:  681 701 1080 1027 454 414 108 90 161 148 60 76 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
228 
disease_progression 
H-positive risk:  704 689 91 1029 417 107 1072 452 147 73 160 59 
H-negative risk:  689 704 1072 1029 452 417 107 91 160 147 59 73 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
229 
disease_progression 
H-positive risk:  710 687 92 1023 420 107 1067 458 149 74 154 59 
H-negative risk:  687 710 1067 1023 458 420 107 92 154 149 59 74 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
230 
disease_progression 
H-positive risk:  715 685 91 1029 413 108 1065 458 151 72 155 58 
H-negative risk:  685 715 1065 1029 458 413 108 91 155 151 58 72 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
231 
disease_progression 
H-positive risk:  713 678 89 1036 416 106 1067 461 149 74 154 57 
H-negative risk:  678 713 1067 1036 461 416 106 89 154 149 57 74 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
232 
disease_progression 
H-positive risk:  722 681 91 1029 422 104 1057 459 151 72 156 56 
H-negative risk:  681 722 1057 1029 459 422 104 91 156 151 56 72 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
233 
disease_progression 
H-positive risk:  717 687 95 1035 423 106 1055 458 148 70 150 56 
H-negative risk:  687 717 1055 1035 458 423 106 95 150 148 56 70 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
234 
disease_progression 
H-positive risk:  720 683 95 1036 429 106 1056 456 149 68 149 53 
H-negative risk:  683 720 1056 1036 456 429 106 95 149 149 53 68 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
235 
disease_progression 
H-positive risk:  720 677 94 1033 442 106 1058 450 149 67 152 52 
H-negative risk:  677 720 1058 1033 450 442 106 94 152 149 52 67 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
236 
disease_progression 
H-positive risk:  715 681 94 1039 433 106 1068 445 146 65 153 55 
H-negative risk:  681 715 1068 1039 445 433 106 94 153 146 55 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
237 
disease_progression 
H-positive risk:  718 690 92 1036 428 105 1076 436 143 69 153 54 
H-negative risk:  690 718 1076 1036 436 428 105 92 153 143 54 69 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
238 
disease_progression 
H-positive risk:  721 692 92 1047 417 101 1077 437 143 67 152 54 
H-negative risk:  692 721 1077 1047 437 417 101 92 152 143 54 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
239 
disease_progression 
H-positive risk:  724 688 90 1053 414 103 1082 433 139 69 151 54 
H-negative risk:  688 724 1082 1053 433 414 103 90 151 139 54 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
240 
disease_progression 
H-positive risk:  716 688 86 1057 416 100 1082 437 140 70 155 53 
H-negative risk:  688 716 1082 1057 437 416 100 86 155 140 53 70 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
241 
disease_progression 
H-positive risk:  718 688 88 1039 435 98 1076 437 143 70 157 51 
H-negative risk:  688 718 1076 1039 437 435 98 88 157 143 51 70 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
87 new agents 
242 
disease_progression 
H-positive risk:  718 693 88 1035 429 102 1080 434 145 68 155 53 
H-negative risk:  693 718 1080 1035 434 429 102 88 155 145 53 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
243 
disease_progression 
H-positive risk:  713 695 90 1034 421 101 1080 440 153 66 153 54 
H-negative risk:  695 713 1080 1034 440 421 101 90 153 153 54 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
244 
disease_progression 
H-positive risk:  711 696 91 1024 425 101 1088 436 149 69 153 57 
H-negative risk:  696 711 1088 1024 436 425 101 91 153 149 57 69 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
245 
disease_progression 
H-positive risk:  711 693 88 1038 417 99 1091 425 153 71 153 61 
H-negative risk:  693 711 1091 1038 425 417 99 88 153 153 61 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
246 
disease_progression 
H-positive risk:  707 696 90 1037 418 98 1095 421 155 70 152 61 
H-negative risk:  696 707 1095 1037 421 418 98 90 152 155 61 70 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
247 
disease_progression 
H-positive risk:  707 704 92 1029 418 98 1100 419 153 66 154 60 
H-negative risk:  704 707 1100 1029 419 418 98 92 154 153 60 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
248 
disease_progression 
H-positive risk:  703 709 93 1032 418 97 1098 421 152 67 151 59 
H-negative risk:  709 703 1098 1032 421 418 97 93 151 152 59 67 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
249 
disease_progression 
H-positive risk:  698 711 94 1035 420 99 1106 410 151 70 148 58 
H-negative risk:  711 698 1106 1035 410 420 99 94 148 151 58 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
250 
disease_progression 
H-positive risk:  698 720 94 1023 421 99 1107 407 153 70 149 59 
H-negative risk:  720 698 1107 1023 407 421 99 94 149 153 59 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
251 
disease_progression 
H-positive risk:  691 724 91 1016 432 100 1105 407 155 70 148 61 
H-negative risk:  724 691 1105 1016 407 432 100 91 148 155 61 70 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
91 new agents 
252 
disease_progression 
H-positive risk:  697 720 91 1027 430 102 1095 403 152 70 150 63 
H-negative risk:  720 697 1095 1027 403 430 102 91 150 152 63 70 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
253 
disease_progression 
H-positive risk:  699 718 91 1030 424 102 1095 405 155 70 151 60 
H-negative risk:  718 699 1095 1030 405 424 102 91 151 155 60 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
91 new agents 
254 
disease_progression 
H-positive risk:  698 719 93 1040 421 106 1092 402 154 69 146 60 
H-negative risk:  719 698 1092 1040 402 421 106 93 146 154 60 69 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
255 
disease_progression 
H-positive risk:  700 718 94 1047 413 106 1081 405 157 71 145 63 
H-negative risk:  718 700 1081 1047 405 413 106 94 145 157 63 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
256 
disease_progression 
H-positive risk:  699 709 97 1055 406 106 1084 411 156 68 146 63 
H-negative risk:  709 699 1084 1055 411 406 106 97 146 156 63 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
257 
disease_progression 
H-positive risk:  699 708 95 1055 407 105 1086 414 157 70 143 61 
H-negative risk:  708 699 1086 1055 414 407 105 95 143 157 61 70 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
87 new agents 
258 
disease_progression 
H-positive risk:  699 712 95 1055 411 106 1079 416 157 66 140 64 
H-negative risk:  712 699 1079 1055 416 411 106 95 140 157 64 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 75 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
259 
disease_progression 
H-positive risk:  698 716 92 1056 407 107 1076 418 158 67 141 64 
H-negative risk:  716 698 1076 1056 418 407 107 92 141 158 64 67 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 77 35 

clinical_engagement 
diagnosis 
demography 
86 new agents 
260 
disease_progression 
H-positive risk:  704 719 95 1065 399 106 1063 424 158 66 135 66 
H-negative risk:  719 704 1063 1065 424 399 106 95 135 158 66 66 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
90 new agents 
261 
disease_progression 
H-positive risk:  699 720 97 1071 387 105 1071 429 159 64 135 63 
H-negative risk:  720 699 1071 1071 429 387 105 97 135 159 63 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 84 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
262 
disease_progression 
H-positive risk:  694 717 94 1075 383 105 1082 431 155 65 138 61 
H-negative risk:  717 694 1082 1075 431 383 105 94 138 155 61 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 85 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
263 
disease_progression 
H-positive risk:  691 721 93 1071 375 108 1100 426 155 61 140 59 
H-negative risk:  721 691 1100 1071 426 375 108 93 140 155 59 61 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
264 
disease_progression 
H-positive risk:  689 723 95 1064 380 102 1103 421 161 60 145 57 
H-negative risk:  723 689 1103 1064 421 380 102 95 145 161 57 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 86 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
265 
disease_progression 
H-positive risk:  690 722 96 1062 385 100 1097 426 161 58 146 57 
H-negative risk:  722 690 1097 1062 426 385 100 96 146 161 57 58 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 89 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
266 
disease_progression 
H-positive risk:  693 712 98 1075 382 97 1099 421 163 55 148 57 
H-negative risk:  712 693 1099 1075 421 382 97 98 148 163 57 55 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 89 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
267 
disease_progression 
H-positive risk:  693 708 97 1068 388 95 1104 426 161 59 145 56 
H-negative risk:  708 693 1104 1068 426 388 95 97 145 161 56 59 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
268 
disease_progression 
H-positive risk:  687 710 97 1056 392 98 1111 427 162 57 147 56 
H-negative risk:  710 687 1111 1056 427 392 98 97 147 162 56 57 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 92 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
269 
disease_progression 
H-positive risk:  694 708 93 1057 398 98 1109 421 163 56 146 57 
H-negative risk:  708 694 1109 1057 421 398 98 93 146 163 57 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 89 33 

clinical_engagement 
diagnosis 
demography 
89 new agents 
270 
disease_progression 
H-positive risk:  697 706 92 1066 396 100 1102 414 165 57 147 58 
H-negative risk:  706 697 1102 1066 414 396 100 92 147 165 58 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 90 32 

clinical_engagement 
diagnosis 
demography 
56 new agents 
271 
disease_progression 
H-positive risk:  700 706 90 1066 393 100 1101 417 164 55 151 57 
H-negative risk:  706 700 1101 1066 417 393 100 90 151 164 57 55 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 92 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
272 
disease_progression 
H-positive risk:  704 707 90 1074 390 98 1097 413 162 55 152 58 
H-negative risk:  707 704 1097 1074 413 390 98 90 152 162 58 55 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 91 32 

clinical_engagement 
diagnosis 
demography 
66 new agents 
273 
disease_progression 
H-positive risk:  708 705 91 1079 392 93 1091 414 164 56 150 57 
H-negative risk:  705 708 1091 1079 414 392 93 91 150 164 57 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 88 36 

clinical_engagement 
diagnosis 
demography 
66 new agents 
274 
disease_progression 
H-positive risk:  711 693 91 1078 404 92 1088 419 165 54 152 53 
H-negative risk:  693 711 1088 1078 419 404 92 91 152 165 53 54 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 86 36 

clinical_engagement 
diagnosis 
demography 
64 new agents 
275 
disease_progression 
H-positive risk:  709 695 90 1067 416 93 1090 420 160 57 153 50 
H-negative risk:  695 709 1090 1067 420 416 93 90 153 160 50 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 86 36 

clinical_engagement 
diagnosis 
demography 
72 new agents 
276 
disease_progression 
H-positive risk:  702 700 87 1069 409 95 1097 420 161 56 153 51 
H-negative risk:  700 702 1097 1069 420 409 95 87 153 161 51 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 88 36 

clinical_engagement 
diagnosis 
demography 
65 new agents 
277 
disease_progression 
H-positive risk:  696 695 85 1059 414 93 1110 423 160 58 152 55 
H-negative risk:  695 696 1110 1059 423 414 93 85 152 160 55 58 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 88 38 

clinical_engagement 
diagnosis 
demography 
85 new agents 
278 
disease_progression 
H-positive risk:  683 697 87 1059 418 95 1112 422 164 55 153 55 
H-negative risk:  697 683 1112 1059 422 418 95 87 153 164 55 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 85 36 

clinical_engagement 
diagnosis 
demography 
66 new agents 
279 
disease_progression 
H-positive risk:  673 700 88 1060 425 97 1104 428 165 53 152 55 
H-negative risk:  700 673 1104 1060 428 425 97 88 152 165 55 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 84 36 

clinical_engagement 
diagnosis 
demography 
85 new agents 
280 
disease_progression 
H-positive risk:  672 705 85 1057 426 99 1100 435 163 52 150 56 
H-negative risk:  705 672 1100 1057 435 426 99 85 150 163 56 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 83 37 

clinical_engagement 
diagnosis 
demography 
67 new agents 
281 
disease_progression 
H-positive risk:  669 700 85 1063 434 97 1100 427 164 55 149 57 
H-negative risk:  700 669 1100 1063 427 434 97 85 149 164 57 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 85 37 

clinical_engagement 
diagnosis 
demography 
84 new agents 
282 
disease_progression 
H-positive risk:  665 699 89 1066 433 96 1099 429 166 52 151 55 
H-negative risk:  699 665 1099 1066 429 433 96 89 151 166 55 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 85 36 

clinical_engagement 
diagnosis 
demography 
84 new agents 
283 
disease_progression 
H-positive risk:  674 697 86 1070 429 94 1092 427 172 49 152 58 
H-negative risk:  697 674 1092 1070 427 429 94 86 152 172 58 49 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 84 36 

clinical_engagement 
diagnosis 
demography 
84 new agents 
284 
disease_progression 
H-positive risk:  683 699 87 1065 418 95 1095 432 169 48 152 57 
H-negative risk:  699 683 1095 1065 432 418 95 87 152 169 57 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 84 37 

clinical_engagement 
diagnosis 
demography 
70 new agents 
285 
disease_progression 
H-positive risk:  681 686 87 1064 416 95 1102 435 172 49 156 57 
H-negative risk:  686 681 1102 1064 435 416 95 87 156 172 57 49 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 85 37 

clinical_engagement 
diagnosis 
demography 
67 new agents 
286 
disease_progression 
H-positive risk:  676 688 86 1075 410 97 1114 419 171 50 156 58 
H-negative risk:  688 676 1114 1075 419 410 97 86 156 171 58 50 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 83 36 

clinical_engagement 
diagnosis 
demography 
57 new agents 
287 
disease_progression 
H-positive risk:  672 684 85 1082 405 99 1119 419 171 51 156 57 
H-negative risk:  684 672 1119 1082 419 405 99 85 156 171 57 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 80 38 

clinical_engagement 
diagnosis 
demography 
70 new agents 
288 
disease_progression 
H-positive risk:  681 680 85 1085 404 95 1116 412 174 52 156 60 
H-negative risk:  680 681 1116 1085 412 404 95 85 156 174 60 52 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 79 40 

clinical_engagement 
diagnosis 
demography 
79 new agents 
289 
disease_progression 
H-positive risk:  683 683 83 1087 402 95 1115 411 172 53 153 63 
H-negative risk:  683 683 1115 1087 411 402 95 83 153 172 63 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 82 39 

clinical_engagement 
diagnosis 
demography 
81 new agents 
290 
disease_progression 
H-positive risk:  686 684 82 1092 392 91 1120 412 174 53 150 64 
H-negative risk:  684 686 1120 1092 412 392 91 82 150 174 64 53 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 83 39 

clinical_engagement 
diagnosis 
demography 
72 new agents 
291 
disease_progression 
H-positive risk:  687 677 84 1087 400 96 1117 410 174 55 151 62 
H-negative risk:  677 687 1117 1087 410 400 96 84 151 174 62 55 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 82 38 

clinical_engagement 
diagnosis 
demography 
71 new agents 
292 
disease_progression 
H-positive risk:  696 670 82 1088 393 101 1117 415 172 55 152 59 
H-negative risk:  670 696 1117 1088 415 393 101 82 152 172 59 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 78 36 

clinical_engagement 
diagnosis 
demography 
85 new agents 
293 
disease_progression 
H-positive risk:  692 668 84 1098 399 100 1112 410 174 53 152 58 
H-negative risk:  668 692 1112 1098 410 399 100 84 152 174 58 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 78 39 

clinical_engagement 
diagnosis 
demography 
63 new agents 
294 
disease_progression 
H-positive risk:  683 672 85 1093 406 100 1122 406 173 53 152 55 
H-negative risk:  672 683 1122 1093 406 406 100 85 152 173 55 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 78 36 

clinical_engagement 
diagnosis 
demography 
80 new agents 
295 
disease_progression 
H-positive risk:  684 673 83 1103 400 97 1117 409 174 54 151 55 
H-negative risk:  673 684 1117 1103 409 400 97 83 151 174 55 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 76 37 

clinical_engagement 
diagnosis 
demography 
80 new agents 
296 
disease_progression 
H-positive risk:  684 667 79 1102 403 98 1112 410 176 57 154 58 
H-negative risk:  667 684 1112 1102 410 403 98 79 154 176 58 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 79 37 

clinical_engagement 
diagnosis 
demography 
57 new agents 
297 
disease_progression 
H-positive risk:  678 668 78 1095 405 99 1120 415 175 57 155 55 
H-negative risk:  668 678 1120 1095 415 405 99 78 155 175 55 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 78 40 

clinical_engagement 
diagnosis 
demography 
86 new agents 
298 
disease_progression 
H-positive risk:  677 668 79 1095 398 100 1113 428 174 57 159 52 
H-negative risk:  668 677 1113 1095 428 398 100 79 159 174 52 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 76 39 

clinical_engagement 
diagnosis 
demography 
70 new agents 
299 
disease_progression 
H-positive risk:  678 671 78 1087 398 100 1118 426 177 55 162 50 
H-negative risk:  671 678 1118 1087 426 398 100 78 162 177 50 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 77 37 

clinical_engagement 
diagnosis 
demography 
70 new agents 
300 
disease_progression 
H-positive risk:  679 663 78 1086 403 103 1114 431 173 54 162 54 
H-negative risk:  663 679 1114 1086 431 403 103 78 162 173 54 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
73 new agents 
301 
disease_progression 
H-positive risk:  675 669 78 1081 401 103 1109 437 174 55 158 60 
H-negative risk:  669 675 1109 1081 437 401 103 78 158 174 60 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 73 39 

clinical_engagement 
diagnosis 
demography 
102 new agents 
302 
disease_progression 
H-positive risk:  674 672 80 1090 391 98 1112 432 177 58 154 62 
H-negative risk:  672 674 1112 1090 432 391 98 80 154 177 62 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 72 39 

clinical_engagement 
diagnosis 
demography 
77 new agents 
303 
disease_progression 
H-positive risk:  675 671 81 1086 393 99 1108 434 176 57 156 64 
H-negative risk:  671 675 1108 1086 434 393 99 81 156 176 64 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 76 36 

clinical_engagement 
diagnosis 
demography 
87 new agents 
304 
disease_progression 
H-positive risk:  674 669 79 1083 397 97 1118 428 175 57 155 68 
H-negative risk:  669 674 1118 1083 428 397 97 79 155 175 68 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 77 35 

clinical_engagement 
diagnosis 
demography 
100 new agents 
305 
disease_progression 
H-positive risk:  680 673 79 1092 389 96 1114 425 173 57 154 68 
H-negative risk:  673 680 1114 1092 425 389 96 79 154 173 68 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 77 35 

clinical_engagement 
diagnosis 
demography 
75 new agents 
306 
disease_progression 
H-positive risk:  680 671 79 1098 385 95 1112 419 177 59 155 70 
H-negative risk:  671 680 1112 1098 419 385 95 79 155 177 70 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 77 35 

clinical_engagement 
diagnosis 
demography 
55 new agents 
307 
disease_progression 
H-positive risk:  675 664 81 1096 390 95 1119 420 174 61 155 70 
H-negative risk:  664 675 1119 1096 420 390 95 81 155 174 70 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 76 35 

clinical_engagement 
diagnosis 
demography 
92 new agents 
308 
disease_progression 
H-positive risk:  674 659 84 1106 388 95 1125 411 173 58 157 70 
H-negative risk:  659 674 1125 1106 411 388 95 84 157 173 70 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 79 35 

clinical_engagement 
diagnosis 
demography 
77 new agents 
309 
disease_progression 
H-positive risk:  677 658 90 1105 388 96 1120 414 172 57 154 69 
H-negative risk:  658 677 1120 1105 414 388 96 90 154 172 69 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 81 34 

clinical_engagement 
diagnosis 
demography 
69 new agents 
310 
disease_progression 
H-positive risk:  681 654 90 1107 384 94 1123 411 174 58 154 70 
H-negative risk:  654 681 1123 1107 411 384 94 90 154 174 70 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 80 35 

clinical_engagement 
diagnosis 
demography 
86 new agents 
311 
disease_progression 
H-positive risk:  686 655 89 1116 382 93 1120 398 174 61 153 73 
H-negative risk:  655 686 1120 1116 398 382 93 89 153 174 73 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 79 36 

clinical_engagement 
diagnosis 
demography 
76 new agents 
312 
disease_progression 
H-positive risk:  686 658 92 1117 384 95 1115 399 169 62 152 71 
H-negative risk:  658 686 1115 1117 399 384 95 92 152 169 71 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
313 
disease_progression 
H-positive risk:  686 664 91 1117 380 96 1107 407 165 66 151 70 
H-negative risk:  664 686 1107 1117 407 380 96 91 151 165 70 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
314 
disease_progression 
H-positive risk:  691 662 91 1114 377 95 1110 404 168 65 153 70 
H-negative risk:  662 691 1110 1114 404 377 95 91 153 168 70 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
315 
disease_progression 
H-positive risk:  682 666 90 1106 381 95 1108 421 168 65 151 67 
H-negative risk:  666 682 1108 1106 421 381 95 90 151 168 67 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
316 
disease_progression 
H-positive risk:  672 666 92 1121 387 95 1102 414 169 68 152 62 
H-negative risk:  666 672 1102 1121 414 387 95 92 152 169 62 68 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
317 
disease_progression 
H-positive risk:  677 661 94 1120 390 95 1101 410 170 66 152 64 
H-negative risk:  661 677 1101 1120 410 390 95 94 152 170 64 66 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
318 
disease_progression 
H-positive risk:  676 652 95 1114 400 94 1102 417 171 63 153 63 
H-negative risk:  652 676 1102 1114 417 400 94 95 153 171 63 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
319 
disease_progression 
H-positive risk:  679 645 92 1112 404 96 1105 415 174 63 152 63 
H-negative risk:  645 679 1105 1112 415 404 96 92 152 174 63 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
320 
disease_progression 
H-positive risk:  678 650 94 1112 401 97 1103 418 171 62 152 62 
H-negative risk:  650 678 1103 1112 418 401 97 94 152 171 62 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
321 
disease_progression 
H-positive risk:  679 658 95 1106 392 96 1103 420 172 65 153 61 
H-negative risk:  658 679 1103 1106 420 392 96 95 153 172 61 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
322 
disease_progression 
H-positive risk:  674 672 94 1097 393 97 1104 416 174 64 152 63 
H-negative risk:  672 674 1104 1097 416 393 97 94 152 174 63 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
323 
disease_progression 
H-positive risk:  682 670 94 1103 383 97 1097 422 172 65 147 68 
H-negative risk:  670 682 1097 1103 422 383 97 94 147 172 68 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
324 
disease_progression 
H-positive risk:  682 674 98 1100 382 96 1093 426 166 68 145 70 
H-negative risk:  674 682 1093 1100 426 382 96 98 145 166 70 68 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 94 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
325 
disease_progression 
H-positive risk:  678 677 95 1099 382 98 1097 429 163 66 148 68 
H-negative risk:  677 678 1097 1099 429 382 98 95 148 163 68 66 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
326 
disease_progression 
H-positive risk:  674 689 92 1092 383 99 1097 427 163 68 148 68 
H-negative risk:  689 674 1097 1092 427 383 99 92 148 163 68 68 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 95 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
327 
disease_progression 
H-positive risk:  671 688 96 1091 393 97 1089 428 163 71 145 68 
H-negative risk:  688 671 1089 1091 428 393 97 96 145 163 68 71 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
328 
disease_progression 
H-positive risk:  671 683 94 1095 396 98 1080 437 157 76 147 66 
H-negative risk:  683 671 1080 1095 437 396 98 94 147 157 66 76 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
329 
disease_progression 
H-positive risk:  666 682 91 1101 401 99 1079 431 157 76 151 66 
H-negative risk:  682 666 1079 1101 431 401 99 91 151 157 66 76 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
330 
disease_progression 
H-positive risk:  664 682 89 1103 396 99 1078 432 155 80 153 69 
H-negative risk:  682 664 1078 1103 432 396 99 89 153 155 69 80 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
331 
disease_progression 
H-positive risk:  671 680 89 1108 393 94 1076 428 160 79 154 68 
H-negative risk:  680 671 1076 1108 428 393 94 89 154 160 68 79 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
332 
disease_progression 
H-positive risk:  674 676 87 1112 391 94 1081 423 161 79 155 67 
H-negative risk:  676 674 1081 1112 423 391 94 87 155 161 67 79 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
333 
disease_progression 
H-positive risk:  674 684 88 1106 388 99 1084 421 158 77 152 69 
H-negative risk:  684 674 1084 1106 421 388 99 88 152 158 69 77 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
334 
disease_progression 
H-positive risk:  674 686 90 1098 383 100 1089 426 160 74 149 71 
H-negative risk:  686 674 1089 1098 426 383 100 90 149 160 71 74 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
335 
disease_progression 
H-positive risk:  668 694 88 1097 381 100 1089 429 158 75 150 71 
H-negative risk:  694 668 1089 1097 429 381 100 88 150 158 71 75 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
336 
disease_progression 
H-positive risk:  671 694 89 1099 378 101 1075 434 158 77 153 71 
H-negative risk:  694 671 1075 1099 434 378 101 89 153 158 71 77 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
337 
disease_progression 
H-positive risk:  673 694 87 1106 371 101 1081 426 160 75 153 73 
H-negative risk:  694 673 1081 1106 426 371 101 87 153 160 73 75 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
338 
disease_progression 
H-positive risk:  674 690 88 1108 367 95 1079 432 164 76 153 74 
H-negative risk:  690 674 1079 1108 432 367 95 88 153 164 74 76 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
339 
disease_progression 
H-positive risk:  681 694 86 1108 368 95 1078 430 160 77 154 69 
H-negative risk:  694 681 1078 1108 430 368 95 86 154 160 69 77 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
340 
disease_progression 
H-positive risk:  676 698 88 1107 368 92 1080 425 163 75 158 70 
H-negative risk:  698 676 1080 1107 425 368 92 88 158 163 70 75 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
341 
disease_progression 
H-positive risk:  673 698 90 1100 371 94 1080 424 165 75 159 71 
H-negative risk:  698 673 1080 1100 424 371 94 90 159 165 71 75 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
342 
disease_progression 
H-positive risk:  672 704 90 1090 380 93 1083 421 166 75 159 67 
H-negative risk:  704 672 1083 1090 421 380 93 90 159 166 67 75 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
343 
disease_progression 
H-positive risk:  669 706 89 1080 385 94 1092 415 168 73 157 72 
H-negative risk:  706 669 1092 1080 415 385 94 89 157 168 72 73 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
344 
disease_progression 
H-positive risk:  668 706 92 1081 378 96 1099 415 164 75 155 71 
H-negative risk:  706 668 1099 1081 415 378 96 92 155 164 71 75 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
345 
disease_progression 
H-positive risk:  673 713 93 1071 380 96 1094 416 166 73 155 70 
H-negative risk:  713 673 1094 1071 416 380 96 93 155 166 70 73 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
346 
disease_progression 
H-positive risk:  671 719 95 1068 379 98 1095 414 165 73 154 69 
H-negative risk:  719 671 1095 1068 414 379 98 95 154 165 69 73 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
347 
disease_progression 
H-positive risk:  668 726 97 1067 384 98 1088 413 165 70 156 68 
H-negative risk:  726 668 1088 1067 413 384 98 97 156 165 68 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
348 
disease_progression 
H-positive risk:  668 723 99 1076 386 99 1082 408 165 68 158 68 
H-negative risk:  723 668 1082 1076 408 386 99 99 158 165 68 68 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
349 
disease_progression 
H-positive risk:  675 718 100 1081 381 99 1083 413 161 69 157 63 
H-negative risk:  718 675 1083 1081 413 381 99 100 157 161 63 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
350 
disease_progression 
H-positive risk:  671 714 104 1080 392 99 1088 408 154 72 153 65 
H-negative risk:  714 671 1088 1080 408 392 99 104 153 154 65 72 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
351 
disease_progression 
H-positive risk:  671 712 108 1073 394 99 1095 405 151 75 152 65 
H-negative risk:  712 671 1095 1073 405 394 99 108 152 151 65 75 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
352 
disease_progression 
H-positive risk:  668 705 108 1073 397 101 1092 415 151 76 152 62 
H-negative risk:  705 668 1092 1073 415 397 101 108 152 151 62 76 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
353 
disease_progression 
H-positive risk:  675 703 109 1069 398 100 1098 408 153 73 147 67 
H-negative risk:  703 675 1098 1069 408 398 100 109 147 153 67 73 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
354 
disease_progression 
H-positive risk:  680 708 105 1063 398 98 1103 404 154 71 146 70 
H-negative risk:  708 680 1103 1063 404 398 98 105 146 154 70 71 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
355 
disease_progression 
H-positive risk:  675 712 107 1075 391 98 1093 410 154 72 140 73 
H-negative risk:  712 675 1093 1075 410 391 98 107 140 154 73 72 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
356 
disease_progression 
H-positive risk:  674 706 110 1074 398 96 1093 413 153 68 141 74 
H-negative risk:  706 674 1093 1074 413 398 96 110 141 153 74 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
357 
disease_progression 
H-positive risk:  671 710 107 1069 406 94 1093 410 157 66 143 74 
H-negative risk:  710 671 1093 1069 410 406 94 107 143 157 74 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
358 
disease_progression 
H-positive risk:  660 710 105 1079 403 93 1095 411 160 65 144 75 
H-negative risk:  710 660 1095 1079 411 403 93 105 144 160 75 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
359 
disease_progression 
H-positive risk:  664 710 104 1075 415 94 1087 406 160 66 142 77 
H-negative risk:  710 664 1087 1075 406 415 94 104 142 160 77 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
360 
disease_progression 
H-positive risk:  657 710 105 1074 417 87 1099 404 160 66 145 76 
H-negative risk:  710 657 1099 1074 404 417 87 105 145 160 76 66 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
Time difference of 16.17956 mins
This is task 22
date
